Showing results (61-70 of 129) with videos related to
Sort By:
Pageof 13
Cancer|October 15, 1980
Correlation of prognostic factors and blood lymphocyte subtypes in non-Hodgkin's lymphomaJ L Murray, P E Hurtubise, D C Young, et al.The American Journal of Medicine|September 11, 1975
Leukemic reticuloendotheliosis. A study of the origin of the malignant cellG W King, P E Hurtubise, A L Sagone, et al.Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission|September 15, 1998
Chimeric antibodies with specificity for tumor antigens: demonstration of in situ localization to tumors after antibody therapyM N Saleh, A B Tilden, R F Meredith, et al.Hybridoma|July 1, 1986
Phase I clinical trial of CO17-1A monoclonal antibodyA F Lobuglio, M Saleh, L Peterson, et al.Journal of Clinical Immunology|March 1, 1992
Frequent anti-V-region immune response to mouse B72.3 monoclonal antibodyM B Khazaeli, M N Saleh, T Liu, et al.Human Antibodies and Hybridomas|October 1, 1993
An animal model to predict the immunogenicity of murine V regions in humansA M Cartner, R M Conry, A Safavy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccineR M Conry, K O Allen, S Lee, et al.Journal of Biological Response Modifiers|December 1, 1984
Leukocyte interferon as a possible biological response modifier in lymphoproliferative disorders resistant to standard therapyR H Clark, N V Dimitrov, J A Axelson, et al.Journal of the National Cancer Institute|August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspectsA F LoBuglio, M N Saleh, J Lee, et al.The Journal of Urology|June 1, 1987
Development and characterization of a monoclonal antibody to human embryonal carcinomaM B Khazaeli, W H Beierwaltes, G S Pitt, et al.Pageof 13